The asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban
Open Access
- 14 April 2022
- journal article
- research article
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 18 (1) , 438-445
Abstract
The human drugs – the antibiotic linezolid (1) and the anticoagulant rivaroxaban (2) – belong among modern pharmaceutics, which contain an oxazolidine-2-one moiety bearing a stereogenic center. The chirality of these drugs is a fundamental attribute for their biological activity. Herein, one of the efficient asymmetric syntheses of these drugs was studied in detail. Highly enantioselective catalysts were tested in the key step of the synthetic procedure, i.e., the asymmetric Henry reaction, under different reaction conditions, using several starting aldehydes. The corresponding nitroaldols as chiral intermediates in the syntheses of these drugs were obtained in high yields and enantiomeric excesses of up to 91% ee.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- Synthesis, Characterization, Antibacterial and Antifungal Evaluation of Novel Monosaccharide EstersMolecules, 2012
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the RibosomeAntimicrobial Agents and Chemotherapy, 2012
- Update 1 of: C2-Symmetric Chiral Bis(oxazoline) Ligands in Asymmetric CatalysisChemical Reviews, 2011
- Highly Enantioselective Nitroaldol Reactions Catalyzed by Copper(II) Complexes Derived from Substituted 2-(Pyridin-2-yl)imidazolidin-4-one LigandsThe Journal of Organic Chemistry, 2011
- The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitorNature Reviews Drug Discovery, 2010
- Enantioselective nitroaldol (Henry) reaction using copper( ii ) complexes of (−)-sparteineChemical Communications, 2006
- Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa InhibitorJournal of Medicinal Chemistry, 2005
- Highly Efficient Chemoselective Deprotection of O,O-Acetals and O,O-Ketals Catalyzed by Molecular Iodine in AcetoneThe Journal of Organic Chemistry, 2004
- A New Copper Acetate-Bis(oxazoline)-Catalyzed, Enantioselective Henry ReactionJournal of the American Chemical Society, 2003
- Oxazolidinone Structure–Activity Relationships Leading to LinezolidAngewandte Chemie International Edition, 2003